Author Archives: Lu Rahman

#Genetics #Zebrafish

Compound isolated from human sperm could treat genetic disorder

A newly discovered genetic condition caused by faulty protein synthesis which causes delayed development and learning difficulties could be treated by a compound originally isolated from human sperm, say scientists. The University of Manchester researchers, with collaborators from the UK, France and US, identified rare changes in a gene called… Read More

#Editor's Choice #News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Novavax announces rolling review for COVID-19 vaccine authorisation

Novavax has announced the start of the rolling review process for authorisation of NVX-CoV2373, its COVID-19 vaccine, by multiple regulatory agencies. The reviews will continue while the company completes its Phase III trials in the UK and US and through initial authorisation for emergency use granted under country-specific regulations. “The… Read More

#Covid-19 #Editor's Choice #News

#AI / data analytics / healthtech / informatics #Biopharmaceutical #Laboratory data

IDBS and Scitara form lab technology partnership

IDBS, innovator in Biopharmaceutical Lifecycle Management (BPLM), and Scitara, laboratory IoT expert, have partnered to create a solution that aims to extend IDBS Polar BPLM’s laboratory data connectivity and instrument integration capabilities. This integrated solution augments the Polar workflow capabilities , says IDBS, by addressing the challenge of sharing and… Read More

#News

#Covid-19 #Immunology / Virology & Vaccines #Research

Oxford University leads first trial into dosing with alternating vaccines

The University of Oxford has reported  it is to lead the first trial looking into alternating different COVID-19 vaccines, to explore the potential for flexibility in delivery and look for clues as to how to increase the breadth of protection against new virus strains. The study, run by the National… Read More

#Covid-19 #Editor's Choice #News #Trending News

#AI / data analytics / healthtech / informatics #Pharmaceuticals

New AI-powered platform aims to revolutionise pharma marketing

PatientMetRx, an AI-powered social intelligence service from UK data tech company Talking Medicines, has been launched, to give the drug brands insights on patient experience on a scale and depth never previously possible. Specialists in social intelligence for the pharmaceutical industry, Talking Medicines developed PatientMetRx to provide a systematic way… Read More

#News

#Cancer research #Immuno-oncology #Oncology

UCL and AstraZeneca collaborate on immuno-oncology research

Researchers from UCL Division of Infection & Immunity will lead on two collaborative projects with AstraZeneca. The projects’ long-term aim is to contribute to the development of new cancer treatments. These research collaborations will investigate immune checkpoints which are key biochemical pathways that regulate our body’s immune responses. These are… Read More

#Cancer Research #Editor's Choice #News

#Medicinal cannabis #Regulatory

Medical cannabis and regulatory framework in Europe

Medical cannabis is a growing market in Europe – but there is a lack of the usual regulatory framework intended to harmonise marketing of medicines and keep them safe. Arriello Director of Drug Safety Peter Kohut provides a guide to marketing cannabis products in the diverse European market. Medical cannabis… Read More

#News #Regulatory

#Covid-19 #Immunology / Virology & Vaccines

GSK and CureVac collaboration to develop COVID-19 vaccine for multi-variants

GlaxoSmithKline and CureVac have signed a €150m (£132m) deal to jointly develop next generation mRNA vaccines for COVID-19. They aim to work together to develop a single vaccine that can address the multiple emerging variants. GSK will also support the manufacture of up to 100 million doses of CureVac’s first… Read More

#Covid-19 #Editor's Choice #News #Trending News

#CRISPR

Horizon’s iPSC cell line engineering services

Horizon can help researchers work with the biologically relevant cell models (immune cells, induced pluripotent derived cardiac and neural cells, and organoids) that closely mimic the end-stage biology of interest. With over a decade of CRISPR/Cas cell line engineering experience, Horizon’s iPSC editing platform is designed to enable efficient and… Read More

#Resources

#Antibodies

A rapid method to quantitatively screen bispecific antibody using protein A and His1K biosensors

Recent biotechnological advances have fueled development bispecific antibodies (bsAbs) in the last 10 years. However, the functional analysis of bsAbs during bioprocessing adds a challenge for scientists given the wide array of bsAbs populated by many different species, comprising many different formats, and that traditional SPR and ELISA methods for… Read More

#Resources

#Characterisation #Drug discovery #Hits #Kinetics #Library screening

Creoptix launches new way of measuring kinetics to accelerate drug discovery

Creoptix, a Switzerland-based company focused on next-generation bioanalytical instruments, has launched waveRAPID (Repeated Analyte Pulses of Increasing Duration), a novel, label-free kinetic measurement method that is said to be faster than traditional kinetics. The company developed the Creoptix WAVEsystem to enable molecular interactions to be studied in real time, aimimng… Read More

#News